GlaxoSmithKline Stock

Detail	Data
Volume (24h):	8,242,367 shares
P/E Ratio:	18.66
Forward P/E:	8.85
EPS:	2.04 USD
Forward EPS:	4.3 USD
Number of Shares:	2,024,690,048 shares
Market Capitalization:	77,952,131,072.00 USD

The interactive chart displays the price movement of GlaxoSmithKline shares and updates every 15 minutes. It shows both the current price and historical trends. The chart offers various time frames, including daily, weekly, or monthly views, as well as the entire trading history.

Disclaimer: The data provided is for informational purposes only. Despite our efforts to ensure accuracy, it may contain errors or be outdated. We strongly recommend verifying the data from other independent sources. No investment decisions should be made based on this information.

Dividend

The company GlaxoSmithKline pays a dividend of 1.6 USD per share. The annual dividend yield is 4.20%. The average dividend yield over the last 5 years is 4.77%. The payout ratio is 79.84%. The last paid dividend was 0.429 USD, paid on 2025-05-16. The ex-dividend date, the date when shares trade without entitlement to the next dividend, is 2025-05-16.

Dividend	Value
Dividend Amount	The company GlaxoSmithKline pays a dividend of 1.6 USD per share.
Annual Yield %:	4.20 %
Ex-dividend Date:	2025-05-16
5-Year Avg Yield %:	4.77 %
Payout Ratio:	79.84 %
Last Dividend Value:	0.429 USD
Last Dividend Date:	2025-05-16

Analyst Forecast

Most analysts have issued a hold recommendation for GlaxoSmithKline stock. The current number of analysts covering this company is 7. The highest target price is 58 USD, while the lowest target price is 35.25 USD. The median target valuation set by analysts is 40 USD. These forecasts and recommendations provide insight into how analysts view the future stock performance of GlaxoSmithKline.

Analysts	Recommendation
Issued Recommendation:	According to our data, the recommendation for GlaxoSmithKline stock is: hold
Number of Analysts:	7
Highest Target Price:	58 USD
Lowest Target Price:	35.25 USD
Median Target Price:	40 USD

Fundamental Indicators

Indicator	Data
Total Revenue:	31,529,000,960.00 USD
Net Income:	3,152,999,936.00 USD
Price-to-Book (P/B):	10.98
PEG Ratio:	/
Exchange:	NYSE
Industry:	Drug Manufacturers - General
Sector:	Healthcare
Number of Employees:	68629
Country:	United Kingdom

Where to Buy GlaxoSmithKline Stock?

You can purchase GlaxoSmithKline stock on the NYSE under the ticker symbol: GSK. Several stock brokers or banks offer trading services for these stocks. Popular stock brokers like XTB and eToro allow you to buy real stocks and ETFs with zero or minimal commissions. Banks usually charge higher fees. Remember, investing in stocks involves risks, so it's important to carefully consider your financial situation and investment goals.

*To verify the availability of specific stocks on the platform, it's a good idea to first open a free demo account. Not all stocks are available.

Real stocks and ETFs. Low minimum deposit, only 50 EUR. Option to copy trades. Advanced stock analysis and free education.

Trustpilot rating 4.4/5 Google play rating 4.2/5

Invest in Stocks with eToro

★★★★★ 5.0

Real stocks and ETFs + free demo account. Low fees + fast customer support. More than 5,200 instruments available for trading. Free training and education. Regular live streams on YouTube.

Trustpilot rating 3.6/5 Google play rating 4.5/5

Try Free Demo Account

★★★★☆ 4.8

Risk warning: Trading CFDs involves a high risk of financial loss. Between 51%-eToro -89% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

More Information on GlaxoSmithKline Stock

Indicator	Value
Company Revenue:	31,529,000,960.00 USD
EBITDA:	8,654,000,128.00 USD - Positive EBITDA indicates profitable operations before interest, taxes, depreciation, and amortization.
Earnings Per Share:	2.04 USD
Book Value Per Share:	3.47 USD
Total Cash:	4,485,000,192.00 USD
Total Cash per Share:	1.10 USD
Total Debt:	18,432,000,000.00 USD
Debt to Equity Ratio:	1.35
Quick Ratio	0.58
Current Ratio	0.87
Free Cash Flow	5,163,125,248.00 USD
Operating Cash Flow	6,741,000,192.00 USD
Gross Margins	71.92 %
EBITDA Margins	27.45 %
Operating Margins	30.79 %
Profit Margins	10.00 %
Return on Assets	6.6 %
Return on Equity	27.1 %
Earnings Growth (1 year)	54.7%
Revenue Growth (1 year)	2.1 %
Quarterly Earnings Year-over-Year Growth	55.3 %
Market Capitalization	77,952,131,072.00 USD
Enterprise Value	168,933,851,136.00 USD
EV/Revenue	5.358
EV/EBITDA	19.521
Float Shares	3,950,185,652 shares
Shares Outstanding	2,024,690,048 shares
Held Percent Insiders	0.00 %
Held Percent Institutions	18.33 %
Shares Short	16,670,244
Shares Short Prior Month	17,365,710
Date Short Interest	2025-05-30
Short Percentage of Total Shares	0.82 %
Short Ratio	3.18
Beta	0.27
Short Percentage of Float	0.82 %
Implied Shares Outstanding	2,054,720,000

Frequently Asked Questions (FAQ)

1️⃣ Does GlaxoSmithKline pay dividends?

The company GlaxoSmithKline pays a dividend of 1.6 USD per share. At this rate, the annual yield is 4.20 %.

2️⃣ Where to buy GlaxoSmithKline shares?

GlaxoSmithKline shares are traded on the NYSE stock exchange under the ticker: GSK. You can buy or trade them through a variety of stock brokers who provide real stock trading services.

3️⃣ What is the forecast for GlaxoSmithKline shares?

According to our data, the recommendation for GlaxoSmithKline shares is from a total of 7 analysts. The average target price prediction is 40 USD per share.

4️⃣ What is the total number of shares and the value of GlaxoSmithKline on the stock exchange?

The total number of GlaxoSmithKline shares on the exchange is 2,024,690,048.00 shares, which at the current market capitalization gives the company a total valuation of 77,952,131,072.00 USD.